Concord Wealth Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10
Closed -$163 957
2024
Q2
$163 Buy
+10
New +$163 ﹤0.01% 799